OrganizationWHO,,2013,,Global tuberculosis report,,,
McGraw-Hill Medical,,2010,Current medical diagnosis,,,,
OrganizationWHO,,2010,,Global tuberculosis control: WHO report,,,
WoodAJ,IsemanMD,,1993,Treatment of multidrug-resistant tuberculosis,New England Journal of Medicine,329,784,91
BassiliA,BierrenbachA,BroekmansJ,ChadhaV,GlaziouP,,2008,Measuring tuberculosis burden, trends, and the impact of control programmes,The Lancet infectious diseases,8,233,43
TanveerM,HasanZ,SiddiquiAR,AliA,KanjiA,GhebremichealS,,2008,Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan,,8,171,
Organization WHO. Global tuberculosis control:
epidemiology, strategy, financing: WHO report 2009: World
Health Organization; 2009
Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM.
Treatment outcomes of multidrug-resistant tuberculosis: a
systematic review and meta-analysis. PLoS One 2009; 4(9):
e6914.
,2005,Knowledge regarding management of tuberculosis among general practitioners in northern areas of Pakistan,JournalPakistan Medical Association,55,174,
Awofeso N.,: B-D.,,2008,Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment,Bulletin of the World health Organization,86,,
LomtadzeN,AspindzelashviliR,JanjgavaM,MirtskhulavaV,WrightA,BlumbergHM,,2009,Prevalence and risk factors for multidrug-resistant Tuberculosis in Republic of Georgia: a population based study,The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease,13,68,
LawnSD,BrooksSV,KranzerK,NicolMP,WhitelawA,VogtM,,2011,Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study,PLoS medicine,8,e1001067,